• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; SUPRARENAL AORTIC EXTENSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; SUPRARENAL AORTIC EXTENSION Back to Search Results
Model Number A34-34/C80-O20
Device Problems Failure To Adhere Or Bond (1031); Detachment Of Device Component (1104); Leak/Splash (1354)
Patient Problems Failure of Implant (1924); Rupture (2208)
Event Date 02/21/2018
Event Type  Injury  
Manufacturer Narrative
Based on the information received, clinical evaluation confirmed the reported type iiia endoleak with complete aortic component separation, type iiib endoleak of the cuff and rupture.Clinical evaluation was unable to confirm that the patient is to receive no treatment due to deteriorating condition.Additionally, clinical evaluation found a complete crown separation, and hyperdilation of the cuff (76%).The most likely cause of the mid aortic loss of seal was the stretched fabric of the cuff (76%) in combination with aortic remodeling.The most likely cause of the compromised stent graft integrity (stretched and breached) was the use of strata material.The most likely cause of the proximal loss of seal was the complete crown separation that was related to the use of strata material.It was reported the patient would receive no further treatment and was in deteriorating condition.There have been no reports of further negative patient sequelae.The devices remain implanted in the patient and will not be returned; therefore, device evaluation will not be completed.The review of manufacturing lot confirmed all devices met specifications prior to release.The afx bifurcated stent was previously reported to the fda under mfr# 2031527-2018-00175.
 
Event Description
Patient was initially implanted with an afx bifurcated and suprarenal device in 2012.On (b)(6) 2018, the patient presented emergently with an endoleak type iiia and type iiib.The decision was made not to re-intervene due to deteriorating patient condition.No additional event or patient information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
SUPRARENAL AORTIC EXTENSION
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
victor arellano
2 musick
irvine, CA 92618
9495984671
MDR Report Key7524141
MDR Text Key108600954
Report Number2031527-2018-00468
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 04/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date08/31/2015
Device Model NumberA34-34/C80-O20
Device Lot Number1025850-043
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/26/2018
Initial Date FDA Received05/17/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/30/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age87 YR
-
-